Search...
Sun Pharma resolves US antitrust case with $200 mn agreement
I'm PortAI, I can summarize articles.
Sun Pharmaceutical Industries has settled a US antitrust case for $200 million. The company's subsidiaries, SPII and Taro Pharmaceuticals USA, reached an agreement with the End Purchaser Plaintiffs in the In re Generic Pharmaceuticals Pricing Antitrust Litigation. The settlement includes a full release of claims against them, but the payment may decrease if a significant number of insured class members opt out. The agreement awaits court approval.
Source: Business Standard The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments